Literature DB >> 3665979

Gallium-67 imaging in the diagnosis of blastomycosis.

M C Giorgi1, E E Camargo, W P Pinto, G Del Negro.   

Abstract

67Ga imaging was used in a group of 13 untreated patients with documented South American blastomycosis in an attempt to obtain additional information on the site and extent of the lesions. All diagnoses were confirmed by demonstration of the fungi in the lesions or body fluids. Serologic tests were performed on all patients. 67Ga imaging was correlated with X-ray in all patients, and with bone imaging when bony lesions were suspected. 67Ga imaging was positive for all lesions detected on chest X-ray and by clinical evaluation. More importantly, lesions clinically unsuspected and missed by other diagnostic techniques were shown on 67Ga imaging: bony and hepatic lesions in three patients; a brain lesion in one patient and parotid gland involvement in five patients. There was good agreement between 67Ga imaging and clinical and laboratory data, scintigraphy being more sensitive. Follow-up studies after specific therapy demonstrated decreased uptake in the lungs and other sites. 67Ga imaging is a useful tool for detection of suspected and unsuspected lesions of blastomycosis and to evaluate the response of the disease to specific therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3665979     DOI: 10.1007/bf00256555

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  16 in total

1.  Utility of bone scanning in disseminated coccidioidomycosis: case report.

Authors:  T G Armbuster; T G Goergen; D Resnick; A Catanzaro
Journal:  J Nucl Med       Date:  1977-05       Impact factor: 10.057

2.  Lacrimal, parotid and mediastinal uptake of gallium 67 in sarcoidosis.

Authors:  J W Lauver; N S Gooneratne
Journal:  Br J Radiol       Date:  1979-07       Impact factor: 3.039

3.  Scanning malignant neoplasms with gallium 67.

Authors:  C L Edwards; R L Hayes
Journal:  JAMA       Date:  1970-05-18       Impact factor: 56.272

4.  The pathologic basis of the strontium bone scan. Studies following administration of strontium chloride Sr 85 and strontium nitrate Sr 85.

Authors:  N D Charkes; I Young; D M Sklaroff
Journal:  JAMA       Date:  1968-12-09       Impact factor: 56.272

5.  Gallium scanning in the diagnosis of liver disease.

Authors:  O James; E J Wood; S Sherlock
Journal:  Gut       Date:  1974-05       Impact factor: 23.059

6.  Gallium-67-citrate scanning in primary cancer of the liver: diagnostic value in the presence of cirrhosis and relation to alpha-fetoprotein.

Authors:  J Levin; M C Kew
Journal:  J Nucl Med       Date:  1975-10       Impact factor: 10.057

7.  Detection of hepatoma in liver cirrhosis.

Authors:  R Moreau; F Soussaline; S Chauvaud; C Parmentier; R Di Paola; P Charbord; M Tubiana
Journal:  Eur J Nucl Med       Date:  1977-09-30

8.  Diagnostic value of gallium and bone scans in evaluation of extrapulmonary coccidioidal lesions.

Authors:  R C Stadalnik; E Goldstein; P D Hoeprich; P A dos Santos; K K Lee
Journal:  Am Rev Respir Dis       Date:  1980-04

Review 9.  Classic and contemporary imaging of coccidioidomycosis.

Authors:  J P McGahan; D S Graves; P E Palmer; R C Stadalnik; A B Dublin
Journal:  AJR Am J Roentgenol       Date:  1981-02       Impact factor: 3.959

Review 10.  Mechanism of gallium-67 accumulation in inflammatory lesions.

Authors:  M F Tsan
Journal:  J Nucl Med       Date:  1985-01       Impact factor: 10.057

View more
  5 in total

1.  Gallium scintigraphy in Hansen's disease.

Authors:  F J Braga; E B Araújo; E E Camargo; L C Tedesco-Marchesi; M C Rivitti; H Bouladour; P Galle
Journal:  Eur J Nucl Med       Date:  1991

2.  Delayed diagnosis of fungal osteomyelitis with early scintigraphic lesions in a dog.

Authors:  Louis-Philippe de Lorimier; Timothy M Fan
Journal:  Can Vet J       Date:  2010-12       Impact factor: 1.008

3.  The role of gallium-67 scan in defining the extent of disease in an endemic deep mycosis, paracoccidioidomycosis: a predominantly multifocal disease.

Authors:  L Y I Yamaga; G Benard; F H Hironaka; L G Castro; M G Funari; C C de Castro; C Guertzenstein; T Watanabe; C Buchpiguel; G G Cerri; M A Shikanai-Yasuda
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-23       Impact factor: 9.236

Review 4.  Paracoccidioidomycosis: an update.

Authors:  E Brummer; E Castaneda; A Restrepo
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

5.  Ga-67 scintigraphy in chromomycosis.

Authors:  M Sato; T Takeda; S Sugahara; N Ishikawa; M Akisada
Journal:  Ann Nucl Med       Date:  1989-03       Impact factor: 2.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.